Similar Search Results

Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany

Kuhlmann, Alexander; Schulenburg, Johann-Matthias von der - In: The European journal of health economics : HEPAC ; … 18 (2017) 3, pp. 273-292

Persistent link: https://www.econbiz.de/10011868215

Public misunderstanding of pivotal COVID-19 vaccine trials may contribute to New Zealand's adoption of a costly and economically inefficient vaccine mandate

Gibson, John K. - In: New Zealand economic papers 57 (2023) 1, pp. 31-40

Persistent link: https://www.econbiz.de/10014281212

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting : the case of Thailand at start of the pandemic

Wang, Yi; Nantasit Luangasanatip; Wirichada Pan–ngum; … - In: The European journal of health economics 24 (2023) 5, pp. 735-748

Persistent link: https://www.econbiz.de/10014328090

The economics of vaccinating or dosing cattle against disease : a simple linear cost-benefit model with modifications

Tisdell, Clement A.; Ramsay, Gavin C. - 1995

Persistent link: https://www.econbiz.de/10000948140

Lifecycle model-based evaluation of infant 4CMenB vaccination in the UK

Sevilla, J. P.; Tortorice, Daniel L.; Kantor, David; … - In: The European journal of health economics 25 (2024) 7, pp. 1133-1146

Persistent link: https://www.econbiz.de/10015141765

Vaccination of poultry against Campylobacter in the EU : what are the economic benefits?

Jensen, Hans G.; Jensen, Jørgen D. - In: Food economics : the official journal of the Nordic … 9 (2012), pp. 1-10

Persistent link: https://www.econbiz.de/10010259902

Economic evaluation of meningococcal vaccines : considerations for the future

Christensen, Hannah; Al-Janabi, Hareth; Lévy, Pierre; … - In: The European journal of health economics : HEPAC ; … 21 (2020) 2, pp. 297-309

Persistent link: https://www.econbiz.de/10012221975

Benefit-Cost Analysis of Rubella Vaccination Policy

Schoenbaum, Stephen C. - 2016

To analyze rubella vaccination strategies we calculated benefits and costs of prevention of rubella. With no … vaccination, lifetime expenditures for congenital rubella syndrome in offspring of females are greater than $35 per female ….00 per person. Vaccination of females at 12 years of age yields net benefits 80 per cent larger than vaccination of children …

Persistent link: https://www.econbiz.de/10014129661

Enhancing affordability and profit in a non-cooperative, coordinated, hypothetical pediatric vaccine market via sequential optimization

Alves-Maciel, Bruno; Proano, Ruben A. - In: Health care management science : a new journal serving … 27 (2024) 3, pp. 436-457

Persistent link: https://www.econbiz.de/10015079878

On the optimal production capacity for influenza vaccine

Forslid, Rikard; Herzing, Mathias - In: Health economics 24 (2015) 6, pp. 726-741

Persistent link: https://www.econbiz.de/10011318499